ARS Pharmaceuticals (SPRY) Interest Coverage Ratio Growth (3y) (2023 - 2026)
ARS Pharmaceuticals (SPRY) Interest Coverage Ratio Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -42.41% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 28.11% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -6.89% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 79.27% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 29.47% |
| 10 | ARS Pharmaceuticals | 595.78 Mn | 394.81 Mn | - | -1,426.86% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,426.86% |
| Dec 31, 2025 | 51.35% |
| Sep 30, 2025 | -4.56% |
| Jun 30, 2025 | 32.38% |
| Mar 31, 2025 | -1,189.14% |
| Dec 31, 2024 | -43.13% |
| Sep 30, 2024 | 46.26% |
| Jun 30, 2024 | -13.45% |
| Mar 31, 2024 | 84.41% |
| Sep 30, 2023 | 96.16% |
| Jun 30, 2023 | 96.81% |
| Mar 31, 2023 | 96.70% |